HE1 COST-EFFECTIVENESS OF 1ST LINE CHEMOTHERAPY REGIMENS IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER AMONG PATIENTS RECEIVING CARE IN THE OUTPATIENT COMMUNITY SETTING
Abstract
Authors
JR Hoverman G Pohl SK Gruschkus M Marciniak M Forsyth G Peltz